Finance

Lists
DPHARMA:KLSE
Duopharma Biotech Bhd
MYR 1,16
0,00%
(0,00) 1D
5 Nov., 10:03:10 GMT+8  ·   MYR
All symbols
SymbolPriceChange% Change
Generating top insights for DPHARMA...
Open
MYR 1,16
High
MYR 1,16
Low
MYR 1,16
Mkt. cap
1,12 mjd
Avg. vol.
234,24 k
Volume
17,10 k
Dividend
3,92%
Quarterly dividend
MYR 0,01
Ex-dividend date
03 Sep. 2026
P/E ratio
10,92
52-wk high
MYR 1,57
52-wk low
MYR 1,06
EPS
MYR 0,11
Shares outstanding
961,94 m
No. of employees
2 k
Open
MYR 1,16
High
MYR 1,16
Low
MYR 1,16
Mkt. cap
1,12 mjd
Avg. vol.
234,24 k
Volume
17,10 k
Dividend
3,92%
Quarterly dividend
MYR 0,01
Ex-dividend date
03 Sep. 2026
P/E ratio
10,92
52-wk high
MYR 1,57
52-wk low
MYR 1,06
EPS
MYR 0,11
Shares outstanding
961,94 m
No. of employees
2 k
News stories
From web sources and news partners
About Duopharma Biotech Bhd
CEO-
Employees2 k
Founded1978
Headquarters-
SectorPharmaceutical industry
Industry-
Previous reportsAll values in MYR
Loading Previous Earnings...
Revenue
Net income
All values in MYR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
222,49 m
224,69 m
247,88 m
234,36 m
Cost of goods sold
131,74 m
128,63 m
150,58 m
134,89 m
Cost of revenue
131,74 m
128,63 m
150,58 m
134,89 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56,11 m
64,37 m
52,42 m
55,74 m
Operating expense
56,18 m
66,90 m
52,88 m
55,60 m
Total operating expenses
187,93 m
195,53 m
203,46 m
190,50 m
Operating income
34,56 m
29,15 m
44,42 m
43,86 m
Other non operating income
-
-590,00 k
-
-
EBT including unusual items
29,68 m
24,91 m
40,41 m
39,30 m
EBT excluding unusual items
29,68 m
24,90 m
40,41 m
39,30 m
Income tax expense
7,11 m
5,86 m
9,69 m
9,43 m
Effective tax rate
23,96%
23,52%
23,99%
24,00%
Other operating expenses
76,00 k
2,00 m
468,00 k
-130,00 k
Net income
22,57 m
19,05 m
30,71 m
29,87 m
Net profit margin
10,14%
8,48%
12,39%
12,75%
Earnings per share
-
-
-
-
Interest and investment income
1,53 m
1,52 m
1,58 m
1,34 m
Interest expense
-6,40 m
-5,19 m
-5,60 m
-5,89 m
Net interest expenses
-4,88 m
-3,67 m
-4,02 m
-4,56 m
Depreciation and amortization charges
-
-
-
-
EBITDA
45,74 m
32,61 m
55,43 m
54,75 m
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google-programme